PIK3CD and immunodeficiency disease: Further, the Monte Carlo method was used to simulate initial dosages of sirolimus in pediatric patients with PIK3CD mutation-related immunodeficiency disease based on the final model, and where the target concentration window of sirolimus was 5–15 ng/ml.